IMMUPHARMA PLC Logo

IMMUPHARMA PLC

Specialty biopharmaceutical company developing peptide-based therapeutics.

IMM | IL

Overview

Corporate Details

ISIN(s):
GB0033711010
LEI:
213800VZKGHXC7VUS895
Country:
United Kingdom
Address:
One, EC1A 7BL London

Description

ImmuPharma PLC is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The company's primary focus is on creating novel treatments for serious medical conditions with significant unmet needs. Its core activities involve advancing a pipeline of drug candidates through research and various stages of clinical development, leveraging its expertise in peptide technology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-06 08:20
Attending JPMorgan Conference & Biotech Showcase
English HTML 13.1 KB
2025-11-24 08:20
Corporate Update
English HTML 16.2 KB
2025-11-04 08:25
Holding(s) in Company
English HTML 50.5 KB
2025-10-27 08:00
IMMUPHARMA ATTENDING BIO-EUROPE
English HTML 11.4 KB
2025-10-23 08:00
Launch of Website; Corporate Update
English HTML 15.0 KB
2025-10-13 08:00
Appointment of Independent Non-Executive Director
English HTML 16.6 KB
2025-10-06 16:22
Holding(s) in Company
English HTML 52.3 KB
2025-09-17 08:00
Exercise of Warrants
English HTML 14.9 KB
2025-09-11 08:00
Exercise of Warrants
English HTML 14.9 KB
2025-09-01 15:12
Appointments of CSO and Head of R&D
English HTML 15.0 KB
2025-09-01 14:20
ImmuPharma Files New Patent Application for P140:
English HTML 29.6 KB
2025-08-20 14:36
Holding(s) in Company
English HTML 52.0 KB
2025-08-06 08:00
Interim Results
English HTML 324.7 KB
2025-06-12 13:51
Result of AGM
English HTML 19.8 KB
2025-05-27 16:13
Holding(s) in Company
English HTML 52.0 KB

Automate Your Workflow. Get a real-time feed of all IMMUPHARMA PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMMUPHARMA PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMMUPHARMA PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.